Clinical Pathology Laboratories (CPL) has validated the Diasorin LIAISON® Meridian H. pylori Stool Antigen(HPSA) test to replace the TechLab® H. pylori CHEKTM test.
- The Diasorin LIAISON® Meridian HPSA test and TechLab® H. pylori CHEKTM test are FDA approved.
- Diasorin LIAISON® Meridian HPSA is a chemiluminescent immunoassay (CLIA) method.
- TechLab® H. pylori CHEKTM is an enzyme immunoassay (EIA) method.
- The Diasorin® and TechLab® methods are analytically equivalent according to CDC and CPL evaluations.
- CPL has confirmed the Diasorin® method to be highly sensitive and specific.
Specimen Acceptability
The Diasorin LIAISON® Meridian HPSA test specimen requirements are:
|
|
Acceptable | Not Acceptable |
---|
Effective April 24, 2023, CPL will be changing from the TechLab® H. pylori CHEKTM test to Diasorin LIAISON® Meridian HPSA for use in the following tests:
4499 | H. PYLORI AG, STOOL |
Test Code | Name |
---|
Please contact your local CPL representative should you have any questions regarding these changes.
References
LIAISON Meridian H. pylori SA. Package Insert. DiaSorin Inc. EN-53759-2020-09.